January 15, 2021

Clinical Outcomes From COVID-19 Following Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers Among Patients with Hypertension in South Korea: A Nationwide Study

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): treatment

Recorded use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) in the 30 days preceding their COVID-19 diagnosis was not associated with all-cause mortality or respiratory events in a cohort of 682 people with hypertension who tested positive for COVID-19. ACEI/ARB use was associated with lower rates of use of mechanical ventilation, ICU admission, and sepsis among COVID-19 patients.

Kim et al. (Dec 29, 2020). Clinical Outcomes From COVID-19 Following Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers Among Patients with Hypertension in South Korea: A Nationwide Study. Epidemiology and Health. https://doi.org/10.4178/epih.e2021004